Yuan-ching Chang

92, Chung Shan North Road
TPQ 10449, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

Journal: Journal of breast cancer

Published: April 09, 2026

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Journal: Molecular cell

Published: July 24, 2025

Cyanidin-3-glucoside Hinders Neoplastic Progression in a Spontaneous Mammary Tumor Model.

Cyanidin-3-glucoside Hinders Neoplastic Progression in a Spontaneous Mammary Tumor Model.

Journal: Anticancer research

Published: April 11, 2025

Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Journal: Cancers

Published: January 12, 2025

Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer.

Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer.

Journal: Journal of breast cancer

Published: September 24, 2024

Select gene mutations associated with survival outcomes in ER-positive ERBB2-negative early-stage invasive breast cancer: A single-institutional tissue bank study.

Select gene mutations associated with survival outcomes in ER-positive ERBB2-negative early-stage invasive breast cancer: A single-institutional tissue bank study.

Journal: Cancer medicine

Published: March 27, 2024

FK228 suppress the growth of human malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology.

FK228 suppress the growth of human malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 26, 2024

Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis.

Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis.

Journal: Journal of Cancer

Published: December 26, 2023

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: December 21, 2023

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

Journal: Nature communications

Published: July 13, 2023

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice.

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice.

Journal: Current issues in molecular biology

Published: May 06, 2023

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).

Journal: BMC cancer

Published: April 03, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026